Press Release

Hepatocyte growth factor (HGF) is secreted by human pancreatic stellate cells and present predominantly on cancer cells. Thus, HGF inhibitors has emerged as an effective therapy in preventing local tumor growth. Also, studies have demonstrated that HGF inhibitors are significantly more effective than Gemcitabine in inhibiting tumor angiogenesis and metastasis.

Access Detailed Report Summary: https://www.pharmaproff.com/report/hepatocyte-growth-factor-inhibitor

Studies have demonstrated that the HGF inhibitor can be a novel therapeutics that can be developed as a monotherapy or as combination therapy with RAS-RAF-MEK, AKT-mTOR, and EGFR inhibitors for the treatment of various human cancers. HGF inhibitors have shown potent antineoplastic effects in several clinical trials for the treatment of head and neck squamous cell carcinoma as HGF/c-Met pathway is directly involved in the development of a proliferative, invasive, and metastatic cancer.

Request to Get the Sample Pages at:   https://www.pharmaproff.com/request-sample/1201

AVEO Pharmaceuticals Inc. is in the process of developing Ficlatuzumab as a potent HGF inhibitor antibody that binds to the HGF ligand with high affinity and specificity to inhibit HGF/c-Met biological activities for the treatment of squamous cell carcinoma of the head and neck and acute myeloid leukemia. Galaxy Biotech LLC, Daiichi Sankyo Company Limited, and Taiho Pharmaceutical Co. are some other companies having HGF inhibitor pipeline.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.

About Pharma Proff

Pharma Proff, a brainchild of Prescient & Strategic (P&S) Intelligence Private Limited, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

We, at Pharma Proff, offer comprehensive reports in addition to providing pragmatic consultancy solutions to help our clients develop business strategies—critical to operations, R&D, product commercialization, and collaborations—that warrant enduring and sustainable results.

On the cusp of a new era that celebrates and lives by technology and holds immense potential for growth in the healthcare and pharmaceutical segments, we ensure our clients remain abreast of the changing industry landscape, comprehend the market dynamics analytically, and channelize their resources efficiently to maintain their stronghold in the market.

Contact:

Pharma Proff

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: [email protected]

Web: https://www.pharmaproff.com/

Connect with us: LinkedIn | Twitter | Facebook

This post was originally published on Crypto Coin Guardian